Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Tvardi Therapeutics (TVRD) Interest & Investment Income (2024 - 2025)

Tvardi Therapeutics' Interest & Investment Income history spans 5 years, with the latest figure at $312000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 136.36% to $312000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 135.56% increase, with the full-year FY2025 number at $1.4 million, up 84.07% from a year prior.
  • Interest & Investment Income hit $312000.0 in Q4 2025 for Tvardi Therapeutics, down from $411000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for TVRD hit a ceiling of $411000.0 in Q3 2025 and a floor of $132000.0 in Q4 2024.